सत्याधीशसत्याधीश
SatyaDheesh
India's Ground Truth Record
Pull to refresh
VOL. I · EST. 11.2025 
SatyaDheesh
सत्याधीश
India's Ground Truth Record
LIVE

India’s First Dengue Vaccine Approved: Qdenga Set to Battle Over 2.89 Lakh Cases

GS2Polity · Governance · IR· Health policy & public health· Prelims + Mains·

Why in news

The CDSCO approved Qdenga, India's first dengue vaccine, to address the rising public health threat of dengue infections.

Background

The Central Drugs Standard Control Organisation (CDSCO) granted marketing authorization to Qdenga, manufactured by Takeda GmbH. The vaccine protects against all four dengue virus types in previously infected individuals and DENV-1/DENV-2 in uninfected ones.

Facts for Prelims

  • BodyCDSCO: The national regulatory body for cosmetics, drugs, and medical devices in India.
  • FactIndia recorded over 2.89 lakh dengue cases and 485 deaths in 2023.
  • S&TQdenga: A dengue vaccine administered in two doses, not recommended for children under 6 or adults over 60.
  • FactQdenga vaccine cost ranges between Rs 6,000 and Rs 12,000 per dose.

For Mains

Q. Discuss the significance of vaccine development in managing vector-borne diseases in India and the challenges of ensuring equitable access to such healthcare innovations.

Dimensions to cover in your answer

  • Public health infrastructure
  • Affordability and accessibility
  • Epidemiological surveillance
  • Preventive healthcare strategy

Keywords: Vector-borne diseases · Public health infrastructure · Preventive medicine · Regulatory approval · Epidemiological data

Read the full news →Report a mistake in this noteSource: Indian Express ↗Also: GS3 · Biotechnology & health research

More Social Justice notes

All Social Justice current affairs →

Something wrong, or something missing?

Spotted a mistake in a note, or want a topic, format or PDF that would help your preparation? Write to us. We read every mail and fix errors fast.

Report a mistake →Ask for something →[email protected]

This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.